These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17852459)

  • 1. Primary hemostasis in patients treated with LDL-apheresis for severe familiar hypercholesterolemia: a prospective pilot trial using PFA-100 analysis to rationalize therapeutic LDL-apheresis procedure.
    Blazek M; Blaha M; Pecka M; Blaha V; Masin V; Maly J
    Hematology; 2007 Dec; 12(6):571-6. PubMed ID: 17852459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shear stress-dependent platelet function after LDL cholesterol apheresis.
    Spieker LE; Ruschitzka F; Badimon JJ; Noll G; Corti R
    Thromb Res; 2004; 113(6):395-8. PubMed ID: 15226094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term therapeutic efficacy of lipoprotein apheresis on circulating oxidative stress parameters--A comparison of two different apheresis techniques.
    Kopprasch S; Bornstein SR; Bergmann S; Graessler J; Julius U
    Atheroscler Suppl; 2015 May; 18():80-4. PubMed ID: 25936309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of acquired platelet dysfunctions in uremic and cirrhotic patients using the platelet function analyzer (PFA-100 ): influence of hematocrit elevation.
    Escolar G; Cases A; Viñas M; Pino M; Calls J; Cirera I; Ordinas A
    Haematologica; 1999 Jul; 84(7):614-9. PubMed ID: 10406903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of LDL-Apheresis and Rheohaemapheresis Treatment on Vitamin E.
    Solichová D; Bláha M; Aufartová J; Krcmová LK; Plíšek J; Honegrová B; Kasalová E; Lánská M; Urbánek L; Sobotka L
    J Nutr Sci Vitaminol (Tokyo); 2015; 61(2):105-12. PubMed ID: 26052140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The first results demonstrating efficiency and safety of a double-column whole blood method of LDL-apheresis.
    Hequet O; Le QH; Rigal D; Mekhloufi F; Jaeger S; Sassolas A; Groisne L; Moulin P
    Transfus Apher Sci; 2010 Feb; 42(1):3-10. PubMed ID: 19932056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Extracorporeal elimination of LDL-cholesterol in the treatment of hypercholesterolemia: indications and methods].
    Bláha V; Havel E; Zadák Z; Pidrman V; Bláha M; Kalinová M
    Vnitr Lek; 1995 Oct; 41(10):724-9. PubMed ID: 8578708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of ezetimibe on serum lipids and lipoproteins in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis therapy.
    Yamamoto A; Harada-Shiba M; Endo M; Kusakabe N; Tanioka T; Kato H; Shoji T
    Atherosclerosis; 2006 May; 186(1):126-31. PubMed ID: 16043185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of plasmapheresis on platelet hemostatic capacity in healthy voluntary blood donors detected by the platelet function analyzer PFA-100.
    Feuring M; Gutfleisch A; Ganschow A; Richter E; Eichler H; Dempfle CE; Tillmann HC; Schultz A; Wehling M
    Platelets; 2001 Jun; 12(4):236-40. PubMed ID: 11454258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LDL-apheresis: clinical experience and indications in the treatment of severe hypercholesterolemia.
    Thiery J; Seidel D
    Transfus Sci; 1993 Jul; 14(3):249-59. PubMed ID: 10146336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apheresis-inducible cytokine pattern change in children with homozygous familial hypercholesterolemia.
    Küçükçongar A; Yenicesu I; Tümer L; Kasapkara CS; Ezgü FS; Paşaoğlu O; Demirtaş C; Celik B; Dilsiz G; Hasanoğlu A
    Transfus Apher Sci; 2013 Jun; 48(3):391-6. PubMed ID: 23651865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of the INNOVANCE PFA P2Y test cartridge for the detection of patients with congenital defects of the platelet P2Y₁₂ receptor for adenosine diphosphate.
    Scavone M; Germanovich K; Femia EA; Cattaneo M
    Thromb Res; 2014 Feb; 133(2):254-6. PubMed ID: 24331208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, safety, and tolerability of long-term lipoprotein apheresis in patients with LDL- or Lp(a) hyperlipoproteinemia: Findings gathered from more than 36,000 treatments at one center in Germany.
    Heigl F; Hettich R; Lotz N; Reeg H; Pflederer T; Osterkorn D; Osterkorn K; Klingel R
    Atheroscler Suppl; 2015 May; 18():154-62. PubMed ID: 25936320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of endothelium-dependent coronary vasodilation after a single LDL apheresis in patients with hypercholesterolemia.
    Igarashi K; Tsuji M; Nishimura M; Horimoto M
    J Clin Apher; 2004; 19(1):11-6. PubMed ID: 15095396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The decrease of mean platelet volume after extracorporeal LDL-cholesterol elimination.
    Blaha M; Kostal M; Lanska M; Blaha V; Foralova I; Filip S; Kubisova M; Maly J
    Atheroscler Suppl; 2013 Jan; 14(1):77-81. PubMed ID: 23357146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical long-term results of H.E.L.P.-apheresis].
    Schuff-Werner P
    Z Kardiol; 2003; 92(Suppl 3):III28-9. PubMed ID: 14663598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apheresis technologies for prevention and regression of atherosclerosis: clinical results.
    Bambauer R; Schneidewind JM; Latza R
    ASAIO J; 1999; 45(5):403-7. PubMed ID: 10503615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [LDL-apheresis in the treatment of coronary heart disease. Rationale for a specific adjuvant therapy].
    Seidel D
    Z Kardiol; 2003; 92(Suppl 3):III6-27. PubMed ID: 14663597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)].
    Blessing F; Jaeger BR; Oberhoffer M; Reichart B; Seidel D
    Z Kardiol; 2003; 92(Suppl 3):III42-7. PubMed ID: 14663601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of low-density lipoprotein apheresis on plasma levels of apolipoprotein e4.
    Moriarty PM; Luyendyk JP; Gibson CA; Backes JM
    Am J Cardiol; 2010 Jun; 105(11):1585-7. PubMed ID: 20494666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.